Subscribe to Newsletter

Charlotte Barker

As an Editor at Texere, I’m working closely with our audience to create vibrant, engaging content that reflects the hard work and passion that goes into bringing new medicines to market. I got my start in biomedical publishing as a commissioning editor for healthcare journals and have spent my career covering everything from early-stage research to clinical medicine, so I know my way around. And I can’t think of a more interesting, challenging or important area to be working in.

Content by Charlotte Barker:

 Business & Regulation Business Practice

A Question of Access

| Charlotte Barker

Critics say a report from the UN on access to medicines ignores the real word industry
Manufacture Technology and Equipment

New and Improved

| Charlotte Barker

New technologies in our Innovation Awards… and an expanded editorial team!
Business & Regulation Business Practice

M&A Merry-Go-Round

| Charlotte Barker

Round and round she goes, where she stops nobody knows. How will the current merger and acquisition fever affect the industry?
Business & Regulation Business Practice

Hiding in Plain Sight

| Charlotte Barker

Mislabeled, substandard or falsified medicines are the perfect opportunity for criminals looking for low risks and high rewards.
Discovery & Development Clinical Trials

Clinical Trial Clarity

| Charlotte Barker

Drug makers and regulators are taking steps towards transparency, but is it enough?
Business & Regulation Formulation

A Cat and Mouse Game: The Evolving Landscape of Abuse-Deterrent Formulations

| Charlotte Barker

Abusers are finding ways to circumvent current abuse-deterrent measures, leaving companies in need of new strategies.
Business & Regulation

The Medicine Maker Innovation Awards 2015

| Charlotte Barker

The December issue will feature our inaugural Innovation Awards, recognising the most exciting new technologies of 2015.
Business & Regulation Biosimilars

The Business of Biosimilars

| Charlotte Barker

Sitting Down With… Carsten Brockmeyer, CEO, Formycon, Germany.
Business & Regulation Business Practice

The Epidemic That Cannot Be Ignored

| Charlotte Barker

The US Centers for Disease Control and Prevention has officially declared an “epidemic of prescription drug abuse”.
Business & Regulation Business Practice

The Price is Right?

| Charlotte Barker

Rising drug prices are not helping the industry’s image problem.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

April Issue of The Medicine Maker